These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35211928)

  • 1. Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring.
    Kroschke J; von Stackelberg O; Heußel CP; Wielpütz MO; Kauczor HU
    Rofo; 2022 Jul; 194(7):720-727. PubMed ID: 35211928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach.
    Zhang X; Zhang G; Qiu X; Yin J; Tan W; Yin X; Yang H; Wang H; Zhang Y
    Radiother Oncol; 2024 Feb; 191():110082. PubMed ID: 38195018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.
    Shi L; He Y; Yuan Z; Benedict S; Valicenti R; Qiu J; Rong Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818782788. PubMed ID: 29940810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives.
    Chetan MR; Gleeson FV
    Eur Radiol; 2021 Feb; 31(2):1049-1058. PubMed ID: 32809167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements Using Radiomics.
    Lee G; Bak SH; Lee HY; Choi JY; Park H; Lee SH; Ohno Y; Nishino M; van Beek EJR; Lee KS
    J Thorac Imaging; 2019 Mar; 34(2):103-115. PubMed ID: 30664063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Chen Q; Zhang L; Mo X; You J; Chen L; Fang J; Wang F; Jin Z; Zhang B; Zhang S
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):345-360. PubMed ID: 34402924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature.
    Trivizakis E; Koutroumpa NM; Souglakos J; Karantanas A; Zervakis M; Marias K
    Biomed Eng Online; 2023 Dec; 22(1):125. PubMed ID: 38102586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
    Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
    Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.
    Cucchiara F; Petrini I; Romei C; Crucitta S; Lucchesi M; Valleggi S; Scavone C; Capuano A; De Liperi A; Chella A; Danesi R; Del Re M
    Pharmacol Res; 2021 Jul; 169():105643. PubMed ID: 33940185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.
    Fernández-Pérez G; Sánchez-Escribano R; García-Vicente AM; Luna-Alcalá A; Ceballos-Viro J; Delgado-Bolton RC; Vilanova-Busquets JC; Sánchez-Rovira P; Fierro-Alanis MP; García-Figueiras R; Alés-Martínez JE
    Clin Transl Oncol; 2018 Jul; 20(7):837-852. PubMed ID: 29256154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.
    Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L
    Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics features as predictive and prognostic biomarkers in NSCLC.
    Bortolotto C; Lancia A; Stelitano C; Montesano M; Merizzoli E; Agustoni F; Stella G; Preda L; Filippi AR
    Expert Rev Anticancer Ther; 2021 Mar; 21(3):257-266. PubMed ID: 33216651
    [No Abstract]   [Full Text] [Related]  

  • 15. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.
    Voigt W; Manegold C; Pilz L; Wu YL; Müllauer L; Pirker R; Filipits M; Niklinski J; Petruzelka L; Prosch H
    Curr Opin Oncol; 2020 Jan; 32(1):68-77. PubMed ID: 31714259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
    Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
    Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of imaging features for radiomics analysis.
    Haga A; Takahashi W; Aoki S; Nawa K; Yamashita H; Abe O; Nakagawa K
    J Med Invest; 2019; 66(1.2):35-37. PubMed ID: 31064950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.